Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.65 USD
+0.85 (5.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.65 USD
+0.85 (5.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Zacks News
Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $17.68, representing a +1.67% change from its previous close.
Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Allstate (ALL) Q2 Earnings Beat Estimates on Premium Growth?
by Zacks Equity Research
Allstate's (ALL) second-quarter results are likely to reflect growing net investment income.
Will American International's (AIG) Q2 Earnings Hit a Pothole?
by Zacks Equity Research
American International's (AIG) second-quarter results are likely to reflect lower profits from General Insurance.
Will Prudential (PRU) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to reflect higher spread income, equity market appreciation and growth in indexed variable annuities, partially offset by lower underwriting results.
Is Oscar Health (OSCR) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Oscar Health, Inc. (OSCR) and Acadia Realty Trust (AKR) have performed compared to their sector so far this year.
Will Rising Expenses Play Spoilsport for AON's Q2 Earnings?
by Zacks Equity Research
AON's second-quarter results are likely to reflect growing contributions from its Health Solutions unit.
Do Options Traders Know Something About Oscar Health (OSCR) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Oscar Health (OSCR) stock based on the movements in the options market lately.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Oscar Health, Inc. (OSCR) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $16.19, representing a +1.19% change from its previous close.
Oscar Health, Inc. (OSCR) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed the most recent trading day at $16.59, moving +1.22% from the previous trading session.
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Oscar Health, Inc. (OSCR) and Palomar (PLMR) have performed compared to their sector so far this year.
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYX
Wall Street Bulls Look Optimistic About Oscar Health (OSCR): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Oscar Health (OSCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
5 Low-Leverage Stocks to Buy as Inflation Data Meets Expectation
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may add VITL, TCOM, ATO, STRA & OSCR to your portfolio.
3 Insurance Stocks to Buy as Interest Rates Remain High
by Abhinab Dasgupta
American Coastal (ACIC), Hamilton Insurance (HG) and Oscar Health (OSCR) are three insurance stocks that you can look into as interest rates stay higher for longer.
Oscar Health (OSCR) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYC
Oscar Health, Inc. (OSCR) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Oscar Health (OSCR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Fast-paced Momentum Stock Oscar Health (OSCR) Is Still Trading at a Bargain
by Zacks Equity Research
Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Oscar Health, Inc. (OSCR) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Oscar Health (OSCR) delivered earnings and revenue surprises of 121.43% and 9.50%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYX
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
by Shaun Pruitt
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
Aflac (AFL) Q1 Earnings Beat on Lower Benefits & Expenses
by Zacks Equity Research
Aflac (AFL) estimates improved sales in its Japan business for 2024, buoyed by sales campaigns commencing in the second quarter.